Concentrations of 22 known aldehydes (byproducts of lipid peroxidation
), 5 acyloins, free and total carnitine and acylcarnitines were measur
ed in plasma and urine obtained from pediatric patients with various f
orms of cancer before any treatment, and following treatment with doxo
rubicin or daunorubicin. Aldehydes, before the initiation of chemother
apy, were significantly elevated in cancer patients compared to contro
ls. Aldehydes such as hexanal, heptanal, and malondialdehyde were stri
kingly higher in samples from cancer patients, while trans 4-cis-4-dec
enal was the prominent aldehyde in the blood of controls. In addition,
in each form of cancer the pattern of aldehydes appeared to be unique
when compared to controls, or to others forms of cancer, In cancer pa
tients receiving chemotherapy there was a general trend toward a reduc
tion 24 h after both the first and after the fifth doxorubicin dose. T
hese changes however were not significant statistically due to large i
nter-patient variation. Free and total plasma carnitine levels remaine
d in the normal range, and there a ere no abnormal acylcarnitines dete
cted in urine, Possible hypotheses to explain the elevations in aldehy
des, and the reasons for the changed aldehyde profiles in different fo
rms of cancer are discussed. (C) 1997 Elsevier Science Inc.